Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia

Movement Disorders

Volumn 20, Issue 12, 2005, Pages 1604-1609

  Skogseid, Inger Marie ^a   Røislein, Jo ^b   Claussen, Bjørgulf ^a   Kerty, Emilia ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Botulinum toxin type A; Cervical dystonia; Employment status; Long term treatment

Indexed keywords

BOTULINUM TOXIN; ANTIPARKINSON AGENT;

ACADEMIC ACHIEVEMENT; ADULT; AGE; AGED; ARTICLE; CERVICAL SPINE; CONTROLLED STUDY; DYSTONIA; EMPLOYMENT; FEMALE; HEALTH INSURANCE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PRIORITY JOURNAL; PROBABILITY; SEX DIFFERENCE; TREATMENT OUTCOME; WORK RESUMPTION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; DEMOGRAPHY; LONGITUDINAL STUDY; MIDDLE AGED; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; TIME; TORTICOLLIS;

ADULT; AGED; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CHI-SQUARE DISTRIBUTION; DEMOGRAPHY; EMPLOYMENT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TORTICOLLIS;

EID: 33644943624     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20670     Document Type: Article

References (18)

1. Le KD, Nilsen B, Dietrichs E. Prevalence of primary focal and segmental dystonia in Oslo. Neurology 2003;61:1294-1296.
2. Nutt JG, Muenter MD, Aronson A, et al. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988;3:188-194.
3. Jahanshahi M, Marion M-H, Marsden CD. Natural history of adult-onset idiopathic torticollis. Arch Neurol 1990;47:548-552.
4. Balash Y, Giladi N. Efficacy of pharmacological treatment of dystonia: evidence based review including meta-analysis of the effect of botulinum toxin and other cure options. Eur J Neurol 2004; 11:361-370.
5. Kessler KR, Skutta M, Benecke R. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety and antibody frequency. J Neurol 1999;246:265-274.
6. Hsiung G-YR, Das SK, Ranawaya R, et al. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 2002;17:1288-1293.
7. Skogseid IM, Kerty E. The course of cervical dystonia and patient satisfaction with long-term botulinum toxin A treatment. Eur J Neurol 2005;12:163-170.
8. Ben-Shlomo Y, Camfield L, Warner T, on behalf of the ESDE collaborative group. What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psych 2002; 72:608-614.
9. Müller J, Kemmler G, Wissel J, et al. The impact of blepharospasm and cervical dystoma on health-related quality of life and depression. J Neurol 2002;249:842-846.
10. Hilker R, Schischniaschvili M, Ghaemi M, Jacobs A, Rudolf J. Health related quality of life is improved by botulinurn neurotoxin type A in long term treated patients with focal dystonia. J Neurol Neurosurg Psych 2001;71:193-199.
11. Müller J, Wissel J, Kenrmler G, et al. Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psych 2004;75:749-753.
12. Nickel T, Heinen F, Scheidt CE, et al. Spasmodic torticollis: a multicentre study on behavioural aspects III: psychosocial changes and coping. Behav Neurol 1996;9:89-95.
13. Heinen F, Scheidt CE, Nickel T, et al. Spasmodic torticollis: a multicentre study on behavioural aspects III - signs, symptoms and course. Behav Neurol 1996;9:81-88.
14. Jahanshahi M, Marsden CD. Personality in torticollis: a controlled study. Psychol Med 1988;18:375-387.
15. Ripley BD. Stochastic simulation. New York: John Wiley and Sons; 1994.
16. Evans M, Hastings N, Peacock B. Multinomial distribution. In: Evans M, Hastings N, Peacock B, editors. Statistical distributions. New York: John Wiley and Sons; 2000. p 134-136.
17. Taylor HM, Karlin S. Markov chains: introduction. In: Taylor HM, Karlin S, editors. An introduction to stochastic modeling. Boston: Academic Press; 1994. p 89-166.
18. Krokstad S, Westin S. Disability in society: medical and non-medical determinants for disability pension in a Norwegian total county population study. Soc Sci Med 2004;58:1837-1848.